Evaluating vaccines for HIV using nonhuman primates
Official title: Simian Vaccine Evaluation Unit: Operation of a Nonhuman Primate Breeding Colony
Funded at University of Louisiana at Lafayette · NIH-10138762 · Data updated 2026-11-12
This study is looking at how well new HIV/AIDS vaccines work using Rhesus macaques, which will help scientists find better ways to prevent the virus and support researchers working on these important vaccines.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisiana at Lafayette NIH-funded |
| Lab location | 1 site (Lafayette, United States) |
| Project start | April 1, 2020 |
| Project end | March 31, 2027 |
| Funding year | 2020 |
| Award (this year) | $1,616,284 |
| NIH project number | 75N93020D00008-0-759302000004-1 |
| Project ID | NIH-10138762 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research are individuals at high risk for HIV infection who may eventually receive effective vaccines developed through this research.
✕Less likely to help
Patients who are already living with HIV or those who do not have a risk of HIV exposure may not benefit directly from this research.
What this research studies
This research focuses on the use of nonhuman primates to evaluate potential vaccines for HIV/AIDS. By maintaining a breeding colony of Rhesus macaques, the study aims to support preclinical testing of AIDS vaccines and prevention strategies. Researchers will assess immune responses and vaccine efficacy, which are crucial for developing effective HIV prevention methods. The program is designed to provide resources for NIH-supported researchers throughout all stages of AIDS vaccine research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that prevent or control HIV infection in humans.
How similar studies have gone: Previous research using nonhuman primates for vaccine evaluation has shown promise, indicating that this approach is both established and effective.
Where this research is happening
-
University of Louisiana at Lafayette
Lafayette, United States Active
Researchers
- Principal investigator: Villinger, Francois — University of Louisiana at Lafayette
- Study coordinator: Villinger, Francois
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.